๐
|
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of reninโangiotensinโaldosterone system inhibitors involving 158 998 patients
7 auth.
L. V. van Vark,
M. Bertrand,
K. Akkerhuis,
J. Brugts,
K. Fox,
J. Mourad,
...
E. Boersma
|
8 |
2012 |
8 ๐
|
๐
|
In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study.
14 auth.
J. Cheng,
H. Garcia-Garcia,
Sanneke P. M. de Boer,
I. Kardys,
Jung Ho Heo,
K. Akkerhuis,
R. Oemrawsingh,
R. V. van Domburg,
J. Ligthart,
K. Witberg,
...
E. Regar,
P. Serruys,
R. V. van Geuns,
E. Boersma
|
8 |
2014 |
8 ๐
|
๐ฌ
|
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
E. Boersma,
K. Akkerhuis,
P. Theฬroux,
R. Califf,
E. Topol,
M. Simoons
|
8 |
1999 |
8 ๐ฌ
|
๐ฆ
|
Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary InterventionโRelated Events Different?
7 auth.
K. Akkerhuis,
J. Alexander,
B. Tardiff,
E. Boersma,
R. Harrington,
A. Lincoff,
...
M. Simoons
|
7 |
2002 |
7 ๐ฆ
|
๐
|
Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease.
14 auth.
R. Oemrawsingh,
J. Cheng,
H. Garcia-Garcia,
R. Geuns,
S. D. Boer,
C. ลimลek,
I. Kardys,
M. Lenzen,
R. V. Domburg,
E. Regar,
...
P. Serruys,
K. Akkerhuis,
E. Boersma,
Atheroremo-Nirs Investigators
|
7 |
2014 |
7 ๐
|
๐ข
|
PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
8 auth.
J. Cheng,
R. Oemrawsingh,
H. Garcia-Garcia,
E. Boersma,
R. V. van Geuns,
P. Serruys,
...
I. Kardys,
K. Akkerhuis
|
7 |
2016 |
7 ๐ข
|
๐
|
Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.
17 auth.
J. Cheng,
M. Suoniemi,
I. Kardys,
T. Vihervaara,
S. D. Boer,
K. Akkerhuis,
Marko Sysi-Aho,
K. Ekroos,
H. Garcia-Garcia,
R. Oemrawsingh,
...
E. Regar,
W. Koenig,
P. Serruys,
P. Serruys,
R. Geuns,
E. Boersma,
R. Laaksonen
|
7 |
2015 |
7 ๐
|
๐
|
Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
13 auth.
L. Vark,
I. Lesman-Leegte,
S. Baart,
D. Postmus,
Y. Pinto,
J. Orsel,
B. Westenbrink,
H. Rocca,
A. Miltenburg,
E. Boersma,
...
H. Hillege,
K. Akkerhuis,
Triumph Investigators
|
6 |
2017 |
6 ๐
|
๐
|
Biomarkers of heart failure with normal ejection fraction: a systematic review
8 auth.
J. Cheng,
K. Akkerhuis,
Linda C. Battes,
L. Vark,
H. Hillege,
W. Paulus,
...
E. Boersma,
I. Kardys
|
6 |
2013 |
6 ๐
|
๐
|
Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients[S]
12 auth.
S. Anroedh,
M. Hilvo,
K. Akkerhuis,
Dimple Kauhanen,
K. Koistinen,
R. Oemrawsingh,
...
P. Serruys,
R. Geuns,
R. Geuns,
E. Boersma,
R. Laaksonen,
I. Kardys
|
6 |
2018 |
6 ๐
|
๐ข
|
Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up
16 auth.
A. Schuurman,
M. Vroegindewey,
I. Kardys,
R. Oemrawsingh,
J. Cheng,
S. D. Boer,
H. Garcia-Garcia,
R. Geuns,
E. Regar,
E. Regar,
...
J. Daemen,
N. V. Mieghem,
P. Serruys,
P. Serruys,
E. Boersma,
K. Akkerhuis
|
6 |
2018 |
6 ๐ข
|